US researchers trying to devise an updated coronavirus vaccine for use this autumn would have to settle on a formula as early as June, officials said on Wednesday, even though some clinical trials are just now getting underway, The New York Times reported.
The assessment came during a daylong meeting of outside advisers to the Food and Drug Administration, who convened to strategise about what the nation’s coronavirus vaccine policy should look like moving forward.
Read the full report: The New York Times
READ MORE:
CanSinoBIO’s mRNA Covid Vaccine Cleared For Trials in China
Singapore Vaccine Travel Lanes Boost Visitor Arrivals – Straits Times
Australia PM Says Vaccine Aid Keeps China Off Pacific Islands
